全文获取类型
收费全文 | 10714篇 |
免费 | 750篇 |
国内免费 | 114篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 13篇 |
妇产科学 | 62篇 |
基础医学 | 989篇 |
口腔科学 | 134篇 |
临床医学 | 761篇 |
内科学 | 648篇 |
皮肤病学 | 112篇 |
神经病学 | 37篇 |
特种医学 | 824篇 |
外国民族医学 | 1篇 |
外科学 | 2660篇 |
综合类 | 801篇 |
预防医学 | 357篇 |
眼科学 | 5篇 |
药学 | 591篇 |
中国医学 | 98篇 |
肿瘤学 | 3472篇 |
出版年
2024年 | 8篇 |
2023年 | 83篇 |
2022年 | 292篇 |
2021年 | 386篇 |
2020年 | 384篇 |
2019年 | 365篇 |
2018年 | 466篇 |
2017年 | 418篇 |
2016年 | 279篇 |
2015年 | 435篇 |
2014年 | 798篇 |
2013年 | 604篇 |
2012年 | 590篇 |
2011年 | 694篇 |
2010年 | 514篇 |
2009年 | 635篇 |
2008年 | 675篇 |
2007年 | 554篇 |
2006年 | 516篇 |
2005年 | 375篇 |
2004年 | 317篇 |
2003年 | 277篇 |
2002年 | 228篇 |
2001年 | 215篇 |
2000年 | 185篇 |
1999年 | 133篇 |
1998年 | 155篇 |
1997年 | 143篇 |
1996年 | 91篇 |
1995年 | 102篇 |
1994年 | 75篇 |
1993年 | 60篇 |
1992年 | 57篇 |
1991年 | 73篇 |
1990年 | 41篇 |
1989年 | 52篇 |
1988年 | 50篇 |
1987年 | 22篇 |
1986年 | 30篇 |
1985年 | 25篇 |
1984年 | 21篇 |
1983年 | 13篇 |
1982年 | 18篇 |
1981年 | 22篇 |
1980年 | 28篇 |
1979年 | 28篇 |
1978年 | 16篇 |
1977年 | 15篇 |
1976年 | 9篇 |
1974年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
前列腺带性结构及其雄激素、雌激素、表皮生长因子受体分布特征的研究 总被引:2,自引:0,他引:2
为了探讨雄激素受体(AR)、雌激素受体(ER)、孕激素受体(PR)和表皮生长因子受体(EGFR)在前列腺带性结构中的分布,应用单饱和剂量测定法,分别测定了前列腺移行带、外周带组织中AR、ER、PR和EGFR的含量。结果表明,在11例前列腺增生症(BPH)患者22份标本中,移行带和周围带AR全部阳性;尽管AR浓度个体差异很大,但是两带之间仍有密切相关性(P<0001);周围带AR浓度高于移行带,两带AR浓度均高于PR、ER;PR和ER在前列腺带性结构上没有明显差异。EGFR在移行带明显高于周围带。研究证实了AR、ER、PR,EGFR在前列腺移行带和周围带上的分布特征。 相似文献
22.
目的:本文观察前列腺癌部位声像图特点并与病理对照,以便帮助对前列腺癌诊断及穿刺点的正确选择,提高前列腺穿刺活检阳性率。方法:总结64例经病理证实为前列腺癌的112个部位的经直肠超声声像图,观察有无异常回声肿块和异常血流区域。结果:112个前列腺癌部位其经直肠超声(TRUS)检查发现异常的有90个,占80.4%;TRUS检查未发现可疑之处的为22个,占19.6%。结论:TRUS可作为诊断前列腺癌和前列腺穿刺活检穿刺点选择的重要方法。 相似文献
23.
Endorectal surface coil MR imaging of prostatic carcinoma with the inversion-recovery sequence 总被引:1,自引:0,他引:1
F Parivar V Rajanayagam V Waluch R T Eto L W Jones B D Ross 《Journal of magnetic resonance imaging : JMRI》1991,1(6):657-664
The value of inversion-recovery (IR) sequences in the diagnosis and staging of prostatic carcinoma with magnetic resonance (MR) imaging was studied. Twenty-six patients with carcinoma of the prostate were imaged at 1.5 T with an endorectal surface coil and with a variety of IR sequences and a set of spin-echo (SE) sequences for comparison. Ex vivo prostate specimens were imaged again at the same field strength. The two images were correlated with histologic sections. Cancer was identified with MR imaging in 96% of patients. Of the tumors more than 4 mm in diameter, 87% were identified on T2-weighted SE images, whereas only 26% were identified on IR images. However, IR images may be more useful in local staging of carcinoma. Gross capsular infiltration was present in only two patients; however, it was detectable (and excluded in five other patients) by means of IR images. It was not detectable on SE images. The high quality of images obtained with the endorectal coil was confirmed. The authors conclude that addition of the IR sequence to MR imaging with the endorectal coil may improve the usefulness of this examination. 相似文献
24.
紫杉醇和维甲酸对前列腺癌PC-3细胞的作用 总被引:1,自引:0,他引:1
目的 观察紫杉醇 (PA)和维甲酸 (RA)协同对前列腺癌细胞系PC 3的体外作用 ,并探讨其可能的作用机制。方法 应用光镜形态学、噻唑蓝 (MTT)法、流式细胞仪和免疫细胞化学法观察了 10 -6、10 -7、10 -8mol/L浓度紫杉醇和 10 -5、10 -6、10 -7mol/L浓度维甲酸在体外单药或协同对前列腺癌细胞系PC 3的作用和对细胞DNA含量及CyclinD1表达的影响。 结果 10 -6mol/L以上浓度维甲酸作用 48h可增强 10 -7mol/L以上浓度紫杉醇对前列腺癌PC 3细胞系的生长抑制 [抑制率≥ (5 6.3± 5 .2 ) % ,P <0 .0 5 ] ,增强诱导凋亡作用 [凋亡率≥ (2 0 .5± 2 .3 ) % ,P <0 .0 5 ] ,下调CyclinD1的表达 [表达率≤ (9.2± 1.1) % ]。维甲酸使紫杉醇所致的G2 /M期细胞比例由 (70 .3± 9.3 ) %变为 (5 4.6± 6.7) % ,部分地逆转了其G2 /M期细胞周期阻滞 (P <0 .0 5 )。结论 紫杉醇和维甲酸可以协同增强对前列腺癌细胞系PC 3的生长抑制和诱导凋亡作用 ,显示了紫杉醇和维甲酸协同用于治疗激素非依赖性前列腺癌的可能性。 相似文献
25.
P-glycoprotein (Pgp) is a plasma membrane protein that was first characterised in multidrug resistant cell lines. The occurrence of Pgp in clinical tumors has been widely studied. Recent investigations have begun to focus on the relationship between Pgp detection in tumors and treatment outcome. In several types of tumors, detection of Pgp correlates with poor response to chemotherapy and shorter survival. P-glycoprotein overexpression often occurs upon relapse from chemotherapy but may also occur at the time of diagnosis. Studies of experimental rat liver carcinogenesis have shown that Pgp expression increases in late stages of carcinogenesis, suggesting that Pgp may be involved in tumor progression. While some of the Pgp isoforms are known to transport hydrophobic chemotherapeutic drugs out of tumor cells, the biologic effects of Pgp overexpression in tumor cells are not fully understood, because the spectrum of substrates for Pgp-mediated transport has not been determined. In the rat liver carcinoma model, strong expression of Pgp is associated with a highly vascular stroma, suggesting that Pgp in tumor cells may affect the connective tissue stroma. The regulation of Pgp appears to be complex, and little is known about how it is up-regulated during carcinogenesis. Further studies of the role of Pgp in malignancy may contribute to our understanding of molecular mechanisms which underlie tumor progression. 相似文献
26.
前列腺癌去势术前后雄性激素变化的研究 总被引:7,自引:1,他引:6
目的 :观察前列腺癌去势术前后雄性激素的变化。 方法 :16例前列腺癌病人在手术前后分别采集血清样本 ,用放射免疫法测定睾酮 (T)、游离睾酮 (FT)、双氢睾酮 (DHT)的含量 ,进行对比分析。 结果 :手术前后 ,血清中T、FT、DHT浓度有非常明显的差异 ,手术后分别下降 92 .2 7%、92 .2 6%、5 8.3 6% ,以T、FT下降为主。根据 2次测定的结果采用配对t检验方法 ,P <0 .0 0 1。 结论 :去势术后 ,去除了血清中绝大部分T、FT ,而DHT仅下降5 8.3 6% ,应当继续使用雄性激素受体竞争剂 ,阻止残存的雄性激素作用 相似文献
27.
本文对煤焦沥青诱发大鼠肺癌过程中的病理形态学所见作了报道。整个过程可以分为三个阶段:1.异物反应阶段;2.异常增生和鳞状化生阶段;3.癌肿发生发展阶段。文中对每一个阶段的病理组织学改变做了详细描述。煤焦沥青诱发的大鼠肺癌的特征如下:1.癌肿全都发生在肺的周边部位;2.绝大多数癌肿的组织类型都是高分化鳞状细胞癌;3.多发性,数个至数十个大小不等的肿块布满全肺;4.癌变各个不同阶段的改变可在同一肺脏中出现;5.转移癌较少见。 相似文献
28.
How may clonality be assessed in human tumours? 总被引:1,自引:0,他引:1
29.
Marcel Stokkel Aeilko Zwinderman Jaap Zwartendijk Ernest Pauwels Berthe van Eck-Smit 《European journal of nuclear medicine and molecular imaging》1997,24(10):1215-1220
Between 10% and 25% of patients with newly diagnosed prostate cancer without bone metastases at the time of diagnosis will
develop metastases during follow-up. To determine the value of clinical and biochemical parameters for assessment of prognosis
at the time of diagnosis, a retrospective study was performed in 124 consecutive patients with newly diagnosed prostate cancer
without bone metastases. The mean follow-up was 41 months, during which time 36 patients died and 15 patients developed metastases.
Bone scans were classified from 0 (=normal) through 2 (=abnormal, but not typical for metastases) and were correlated with
age, alkaline phosphatase (AP), prostate-specific antigen (PSA), tumour grade, T-stage and N-stage. In patients with a class
2 scan, additional roentgenograms and follow-up were used to exclude metastases at initial stage. All parameters, including
therapy, were finally correlated with the development of metastases and survival. For survival 38 patients with proven metastases
were used as controls. For all parameters tested, no statistically significant differences were found between the three bone
scan classifications. The interval between diagnosis and the development of metastases ranged from 12 to 72 months. For the
risk of development of metastases only PSA was found to be a significant correlate (P=0.0075). However, when tumour stages were clustered in limited disease (T0–2) and extensive disease (T3–4), the incidence
of metastases was significantly higher in patients with extensive disease than in those with limited disease (P=0.0021). Finally, age, PSA and Anderson classification were found to be significant correlates of survival, but in stepwise
analysis PSA was selected as the most prognostic variable (P<0.0001). In contrast with a typical pattern of metastases on bone scintigraphy, an abnormal scan (class 1 and 2) at the time
of diagnosis is not a poor prognostic parameter of the risk of death. In conclusion, in patients with prostate cancer without
bone metastases at the time of diagnosis, pretreatment PSA and tumour stage can be used for the assessment of risk of development
of metastases during follow-up and survival. For this purpose, tumour stage should be clustered in limited and extensive disease.
Received 14 April and in revised form 9 June 1997 相似文献
30.
目的:采用巢式RT-PCR方法,检测前列腺癌合并骨转移的患者外周血中前列腺特异抗原(PSA)、前列腺特异膜抗原(PSMA)和人腺体激肽释放酶mRNA的表达,探讨其临床意义.方法:应用巢式RT-PCR的方法,检测外周血中PSA、PSMA和hK2mRNA表达.结果:巢式PCR能够检测到经淋巴细胞稀释的LNCaP细胞的PSA、PSM和hK2mRNA的灵敏度,稀释浓度分别为10-6、10-6及10-7.检测初发伴骨转移的前列腺癌患者外周血PSA、PSMA和hK2mRNA的阳性率分别为59.45%、51.35%、59.46%,其中三种检测同时阳性的为32.43%;检测接受内分泌治疗后出现骨转移的前列腺癌患者的阳性率分别为57.14%、85.71%、83.33%,其中三种检测同时阳性的为52.48%.局限性前列腺癌患者、健康男性及健康女性的检测结果均为阴性.以β-actin mRNA做为内参照,所有临床标本检测均为阳性.结论:采用巢式RT-PCR检测前列腺癌患者外周血PSMA、hK2和PSA mRNA有助于发现进入循环系统的前列腺癌细胞,提示隐匿性转移的存在.PSMA和hK2较适合用于内分泌治疗后患者的检测.三种指标联合检测有助于提高敏感性. 相似文献